General29 July 2026· 6 min read
UK MHRA Agility Reform Drives Clinical Trial Innovation
The Medicines and Healthcare products Regulatory Agency (MHRA) is poised to implement the most significant overhaul of British clinical research in 20 years. Effective 28 April 2026, the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (Statutory Instrument…
By Dr. Eleanor Vance, Regulatory Affairs Editor
Research21 July 2026· 11 min read
London AI Models Accelerate Drug Discovery Pipelines
AI-guided target identification is now mandatory in London's pharma R&D pipelines, compressing lead optimisation to 14 months and pushing Phase 1 success rates above 80%. Read on.
By James Whitfield, Manufacturing & Supply Chain Writer
Clinical Trials6 July 2026· 9 min read
DTP3 Signals A New Route for Relapsed Myeloma Care
DTP3 multiple myeloma development targets a cancer-restricted NF-kB survival switch. Could this first-in-class peptide open a new lane for relapsed and refractory patients?
By Tom Okafor, Clinical Trials Correspondent
Clinical Trials29 June 2026· 11 min read
UK sets pathway for in vivo CRISPR gene editing trials
The UK is advancing in vivo CRISPR gene editing beyond ex vivo models. Explore regulatory signals, lipid nanoparticle delivery, and NHS reimbursement challenges.
By Dr. Eleanor Vance, Regulatory Affairs Editor
Clinical Trials17 June 2026· 10 min read
Microbiome on a chip could cut drug trial failures
Microbiome on chip systems could revolutionise drug discovery by providing human-relevant gut testing, potentially reducing the 90% clinical trial failure rate.
By Tom Okafor, Clinical Trials Correspondent
Clinical Trials10 June 2026· 14 min read
UK Clinical Trial Reforms 2026: Accelerating Approvals
The UK clinical trial regulation package, taking effect on 28 April 2026, is designed to deliver faster, more predictable approvals while preserving participant protections. Its headline operational c
By Tom Okafor, Clinical Trials Correspondent
Pharmaceutical16 November 2023· 3 min read
Calliditas Submits Kinpeygo to UK MHRA for IgAN
A Groundbreaking Leap for Kidney Health In the battle against kidney diseases, we've just reached a significant milestone that promises to transform lives. The stage is set, the players are aligned, a
By Priya Raghavan, Biotech & Markets Analyst